Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K8 | P41279 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.30 |
| ▸ | CPA1 | P15085 | 1/20 | 0.30 |
| ▸ | CPB1 | P15086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24925524 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL22833798 | 0.75 | KDM5A (0.40) | CPB2CPB1 | |
| SCHEMBL24655835 | 0.74 | — | — | |
| SCHEMBL2982336 | 0.73 | PDE4A (0.35) | CPB2CPA1CPB1 | |
| SCHEMBL27772454 | 0.72 | — | — | |
| SCHEMBL24655834 | 0.72 | KDM5A (0.44) | — | |
| SCHEMBL16964094 | 0.72 | TDP1 (0.37) | CPB2CPB1 | |
| SCHEMBL24655851 | 0.72 | CPB2 (0.37) | CPB2CPB1 | |
| SCHEMBL2557316 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL2977516 | 0.71 | PDE4A (0.34) | CPB2CPA1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174647-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | NEURON23, INC. | 2024-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174647-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | LRRK2, MAP3K20, MAP3K5 | MAP3K8 22/4885RORC 2673/4885CPB2 3610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.